<i>ARID2</i> Deficiency Enhances Tumor Progression via ERBB3 Signaling in <i>TFE3</i>-Rearranged Renal Cell Carcinoma
<i>TFE3</i>-rearranged Renal Cell Carcinoma (TFE3-RCC) is an aggressive subtype of RCC characterized by Xp11.2 rearrangement, leading to TFE3 fusion proteins with oncogenic potential. Despite advances in understanding its molecular biology, effective therapies for advanced cases remain elusive. This...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI AG
2024-12-01
|
| Serija: | Current Issues in Molecular Biology |
| Teme: | |
| Online pristup: | https://www.mdpi.com/1467-3045/46/12/817 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
